title: Endocrine aspects and sequel in patients with craniopharyngioma.
abstract: A craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5-2.0 cases/million per year and approximately 60% of CP is seen in adulthood. The therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. Typical initial manifestations at diagnosis in children are symptoms of elevated intracranial pressure, visual disturbances and hypopituitarism. CPs have the highest mortality of all pituitary tumours. The standardised overall mortality rate varies from 2.88 to 9.28 in cohort studies. Adults with CP have a 3-19-fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health and reduction in quality of life and cognitive function.
authors.forename: Eva Marie
authors.initials: EM
authors.lastname: Erfurth
mesh_terms: D000293:Adolescent; D000328:Adult; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003397:Craniopharyngioma / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D004700:Endocrine System Diseases / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006728:Hormones / Q000097:blood*; D006801:Humans; D007018:Hypopituitarism / Q000453:epidemiology / Q000209:etiology; D015994:Incidence; D008297:Male; D010911:Pituitary Neoplasms / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D011788:Quality of Life
chemical_list: D006728:Hormones